Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

Milašinović B, Marković S, Vezmar Kovačević S, Svorcan P, Miljković B, Vučićević K

Pharmaceuticals (Basel). 2026 Aug 06; 19(8). PMID: 42653736. Abstract